|
|
|
Volumn 45, Issue 1, 2008, Pages 1-20
|
|
Malaria vaccine: A current perspective
|
|
Author keywords
CSP; Malaria vaccine; P. Vivax; Plasmodium falciparum; Pre erythrocytic stage
|
|
Indexed keywords
4 AMINO ACID REPEAT PEPTIDE;
APICAL MEMBRANE ANTIGEN 1;
CIRCUMSPOROZOITE PROTEIN;
ENOLASE ANTIBODY;
GLYCINE DEHYDROGENASE (DECARBOXYLATING);
MALARIA VACCINE;
MEROZOITE SURFACE POROTEIN 1;
PARASITE ANTIGEN;
PROTEIN EBA 175;
PROTEIN GLURP;
PROTEIN MSP 2;
PROTEIN PFEMP1;
PROTEIN RESA;
PROTEIN SERA;
PROTEIN VAR1CSA;
PROTEIN VAR2CSA;
SPOROZOITE VACCINE;
THROMBOSPONDIN RELATED ADHESION PROTEIN;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
DISEASE ACTIVITY;
DISEASE COURSE;
DRUG EFFICACY;
DRUG MECHANISM;
GENE TECHNOLOGY;
HUMAN;
IMMUNE RESPONSE;
INNATE IMMUNITY;
MALARIA;
NONHUMAN;
PLASMODIUM CYNOMOLGI;
PLASMODIUM FALCIPARUM;
PLASMODIUM KNOWLESI;
PLASMODIUM VIVAX;
PREGNANCY;
REVIEW;
T LYMPHOCYTE;
TREATMENT OUTCOME;
VACCINATION;
ANIMALS;
CHILD;
CHILD, PRESCHOOL;
CLINICAL TRIALS AS TOPIC;
FEMALE;
HUMANS;
INFANT;
MALARIA VACCINES;
MALARIA, FALCIPARUM;
MALARIA, VIVAX;
MICE;
PLASMODIUM FALCIPARUM;
PLASMODIUM VIVAX;
PREGNANCY;
PREGNANCY COMPLICATIONS, PARASITIC;
PROTOZOAN PROTEINS;
|
|
EID: 40449117803
PISSN: 09729062
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (32)
|
|
References (125)
|
